BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report)’s share price fell 2.5% on Friday . The company traded as low as $9.81 and last traded at $9.81. 3,436 shares were traded during trading, an increase of 38% from the average session volume of 2,493 shares. The stock had previously closed at $10.06.
BioSyent Price Performance
The stock has a 50-day moving average price of $10.52 and a 200 day moving average price of $10.01.
BioSyent Company Profile
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Recommended Stories
- Five stocks we like better than BioSyent
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
